Scinovex
articleTop 1% cited

Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging

Neurobiology of Aging · 2010 · Vol. 31(8) · pp. 1275–1283
Christopher C. RoweKathryn A. EllisMiroslava RimajovaPierrick BourgeatKerryn E. PikeGareth JonesJürgen FrippHenri Tochon‐DanguyLaurence MorandeauGraeme O’KeefeRoger I. PriceParnesh RanigaPeter RobinsOscar AcostaNat LenzoCassandra SzoekeOlivier SalvadoRichard HeadRalph N. MartinsColin L. MastersDavid AmesVictor L. Villemagne
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatmentsFunctional Brain Connectivity StudiesPittsburgh compound BDementiaAtrophyAlzheimer's Disease Neuroimaging InitiativeNeuroimagingInternal medicineCognitive declineMedicineAlzheimer's diseaseAmyloid (mycology)

MeSH terms

AgedAged, 80 and overAgingAlzheimer DiseaseAniline CompoundsAustraliaFemaleGenetic Carrier ScreeningHippocampusHumansLongitudinal StudiesMaleMiddle AgedProspective StudiesThiazoles
Citations
990
FWCI
42.26
field-weighted impact
References
33
Percentile
100%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging · Scinovex